Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (61-70 of 869) with videos related to

Pageof 87
Sort By:
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1976
The action of oxamniquine on Leishmania braziliensis braziliensis in hamstersR P Brazil, B Gilbert
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing Sun
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Biometrics|April 27, 2011
Comparing biomarkers as principal surrogate endpointsYing Huang, Peter B Gilbert
Scandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B Gilbert
Lifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B Gilbert
Plos Pathogens|March 25, 2021
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protectionMorgane Rolland, Peter B Gilbert
Biometrics|February 21, 2013
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacyM Juraska, P B Gilbert
Developmental and Comparative Immunology|August 1, 2024
Expression of the receptor for IgM (FcμR) by bovine neutrophilsFlorence B Gilbert, Pascal Rainard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B Gilbert
Pageof 87

Showing results (61-70 of 869) with videos related to

Sort By:
Pageof 87
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1976
The action of oxamniquine on Leishmania braziliensis braziliensis in hamstersR P Brazil, B Gilbert
Biostatistics (Oxford, England)|April 16, 2005
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiationPeter B Gilbert, Yanqing Sun
The Lancet. Haematology|February 9, 2016
Search continues for a CMV vaccine for transplant recipientsMichael Boeckh, Peter B Gilbert
Biometrics|April 27, 2011
Comparing biomarkers as principal surrogate endpointsYing Huang, Peter B Gilbert
Scandinavian Journal of Statistics, Theory and Applications|March 23, 2013
Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing MarksYanqing Sun, Peter B Gilbert
Lifetime Data Analysis|March 24, 2016
Joint modeling of longitudinal and survival data with the Cox model and two-phase samplingRong Fu, Peter B Gilbert
Plos Pathogens|March 25, 2021
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protectionMorgane Rolland, Peter B Gilbert
Biometrics|February 21, 2013
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacyM Juraska, P B Gilbert
Developmental and Comparative Immunology|August 1, 2024
Expression of the receptor for IgM (FcμR) by bovine neutrophilsFlorence B Gilbert, Pascal Rainard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2012
Nomenclature for immune correlates of protection after vaccinationStanley A Plotkin, Peter B Gilbert
Pageof 87